Semaglutide for Cocaine Use Disorder Treatment
- Semaglutide (Ozempic, Wegovy; Novo Nordisk), a weight loss and diabetes glucagon-like peptide-1 (GLP-1) receptor agonist, demonstrated significant reductions in cocaine-seeking behavior in rats, according to research conducted by...
- "This is animal work,so at the moment,we can't say that we have anywhere near a viable treatment for human cocaine dependency.
- Cocaine use disorder (CUD) is a serious condition that impacts millions of individuals globally and does not have an effective pharmacological treatment option. Based on the DSM-5, CUD...
“`html
Semaglutide Shows promise in Reducing Cocaine-Seeking Behavior in Rats
Table of Contents
Study Overview
Semaglutide (Ozempic, Wegovy; Novo Nordisk), a weight loss and diabetes glucagon-like peptide-1 (GLP-1) receptor agonist, demonstrated significant reductions in cocaine-seeking behavior in rats, according to research conducted by scientists from the University of Gothenburg in Sweden and the University of Pennsylvania.The study authors, who published their findings in the journal european Neuropsychopharmacology, noted that the results need to be confirmed in humans but suggest that the drug has the potential of being developed as a treatment for cocaine dependency.1,2
“This is animal work,so at the moment,we can’t say that we have anywhere near a viable treatment for human cocaine dependency. We need a bigger study to confirm these results, and then we need to see if the findings also apply to humans. However, these results are very promising, underlining the need for human studies, especially since there are no existing pharmacological treatments for cocaine dependency,” Elisabet Jerlhag, lead study author and professor at the university of Gothenburg, said in a news release.2
Understanding Cocaine Use Disorder
Cocaine use disorder (CUD) is a serious condition that impacts millions of individuals globally and does not have an effective pharmacological treatment option. Based on the DSM-5, CUD is diagnosed when an individual meets at least 2 of 11 specific criteria within a 12-month period, leading to significant impairment or distress.These criteria are grouped into 4 categories, including psychological symptoms like craving and withdrawal; a loss of control over cocaine use; prioritizing cocaine use over major life responsibilities; and other negative consequences resulting from its use.3
Diagnostic Criteria (DSM-5)
- Impaired Control: Includes using more cocaine than intended or trying unsuccessfully to cut down.
- Social Impairment: Cocaine use leads to problems in relationships or at work/school.
- risky Use: Using cocaine in dangerous situations.
- Pharmacological Criteria: Tolerance (needing more cocaine to get the same effect) and withdrawal symptoms.
semaglutide for cocaine Use Disorder Treatment
Previous research has identified that exenatide (Bydureon; AstraZeneca), a GLP-1 used together with diet and exercise to treat type 2 diabetes (T2D), reduced some cocaine-related behaviors in animals but had limited effects on humans. in the current study, researchers assessed if